Formula Growth LTD Lantheus Holdings, Inc. Transaction History

Formula Growth LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$73.86 - $108.74 $1.93 Million - $2.83 Million	26,069 New	26,069 $2.13 Million
Q4 2023 Feb 13, 2024	SELL	$55.6 - $77.89 $227,960 - $319,349	-4,100 Reduced 8.33%	45,100 $2.8 Million
Q3 2023 Nov 13, 2023	BUY	$60.27 - $90.75 $1.01 Million - $1.52 Million	16,711 Added 51.44%	49,200 $3.42 Million
Q2 2023 Aug 11, 2023	BUY	$82.41 - $99.65 $2.68 Million - $3.24 Million	32,489 New	32,489 $2.73 Million

478

68.9M

522K

312K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $3.64B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

Stay updated on Formula Growth LTD with notifications on news.